Neumora Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Neumora Therapeutics Inc
CIK #0001885522
EDGAR Form CIK 2011 - 2026
10-K [0001885522]
10-Q [0001885522]
3 [0001885522]
4 [0001885522]
8-K [0001885522]
D [0001885522]
SC 13D [0001885522]
SC 13G [0001885522]
Form 13D/13G Filer Form 13D/13G Subject Filed
Invus Global Management LLC Neumora Therapeutics Inc [2026-02-19]
K2 Healthventures Equity Trust LLC Neumora Therapeutics Inc [2025-08-11]
Softbank Group Corp Neumora Therapeutics Inc [2024-11-12]
FMR LLC Neumora Therapeutics Inc [2024-07-08]
FMR LLC Neumora Therapeutics Inc [2024-07-08]
Berns Paul L Neumora Therapeutics Inc [2024-02-14]
Softbank Group Corp Neumora Therapeutics Inc [2024-02-13]
Arch Venture Fund XII LP Neumora Therapeutics Inc [2023-10-02]
Amgen Inc Neumora Therapeutics Inc [2023-09-27]
Form 3/4/5 Subject 2011 - 2026
Neumora Therapeutics Inc
Burow Kristina
Piacquad David
Ho Maykin
Halawa Alaa
Fust Matthew K
Aurora Daljit Singh
Milligan Michael Lee
Berns Paul L
Pinto Joshua
Duncan Jason
Arch Venture Partners X LLC
Arch Venture Partners VIII LLC
Arch Venture Fund X Overage LP
Arch Venture Partners X LP
Arch Venture Fund X LP
Arch Venture Fund VII LP
Arch Venture Fund VIII Overage LP
Arch Venture Partners X Overage LP
Arch Venture Partners VII LP
Arch Venture Partners VII LLC
Arch Venture Fund XII LP
Arch Venture Partners XII LLC
Bybee Clinton
Nelsen Robert
Gillis Steven
Crandell Keith
Arch Venture Partners XII LP
Lenz Robert A
Suh Carol Y
Gosebruch Henry O
FMR LLC
Amgen Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Neumora Therapeutics Inc NMRA
Common Stock
2026-02-17 Sell 6,165 $3.56 21,947
Neumora Therapeutics Inc NMRA
Common Stock
2026-02-17 Sell 9,819 $3.51 34,465
Neumora Therapeutics Inc NMRA
Common Stock
2026-02-17 Sell 1,436 $3.57 5,127
Neumora Therapeutics Inc NMRA
Common Stock
2026-02-17 Sell 5,967 $3.54 21,123
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 750,000 $0.00
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 750,000 $0.00
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 1,200,000 $0.00
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 1,650,000 $0.00
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 350,000 $0.00
Neumora Therapeutics Inc NMRA
Common Stock
2025-11-11 Sell 114,703 $2.68 307,404
Neumora Therapeutics Inc NMRA
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Neumora Therapeutics Inc NMRA
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Neumora Therapeutics Inc NMRA
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 95,586
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 85,391
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 38,234
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 28,675
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 41,250
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2025-05-28 Grant 400,000
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
2025-05-28 Grant 85,391
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com